Madrigal Pharmaceuticals Culture | Comparably

Madrigal Pharmaceuticals Culture Company

Madrigal Pharmaceuticals Culture

Questo punteggio è derivato da dipendenti valutazioni e recensioni

Top Rated Cultura Dimensioni

N/A

CEO di Madrigal Pharmaceuticals

Paul Friedman Madrigal Pharmaceuticals' CEO
Paul Friedman

Madrigal Pharmaceuticals Mission, Vision e Valori

Missione

Madrigal Pharmaceuticals is a clinical-stage biopharmaceutical company pursuing novel therapeutics that target a specific thyroid hormone pathway in the liver, which is a key regulatory mechanism common to a spectrum of cardio-metabolic and fatty liver diseases with high unmet medical need.

Madrigal Pharmaceuticals Culture A colpo d'occhio

1 dipendenti di Madrigal Pharmaceuticals hanno esaminato Madrigal Pharmaceuticals attraverso varie dimensioni della cultura, fornendo le loro opinioni sugli articoli che vanno dai feedback esecutivi al ritmo di lavoro. L'ultima recensione sia stata mesi fa.

Dirigenti con responsabilità strategiche

Nome e Titolo
Bio
Paul Friedman  CEO / President
Paul Friedman
CEO / President
Paul Friedman serve come CEO / President di Madrigal Pharmaceuticals.
Marc R. Schneebaum  Chief Financial Officer and Senior Vice President
Marc R. Schneebaum
Chief Financial Officer and Senior Vice President
Mr. Marc R. Schneebaum has been the Chief Financial Officer and Senior Vice President at Madrigal Pharmaceuticals, Inc. since July 22, 2016. Mr. Schneebaum served as Chief Financial Officer and Senior Vice President of Synta Pharmaceuticals Corp., since December 8, 2014 and served its Treasurer. Mr. Schneebaum has over twenty years of demonstrated success in broad corporate finance, business development, technology development, sales & marketing and general management in life sciences (biotherapeutics, medical devices and diagnostics). He served as Chief Operating Officer of Predictive Biosciences, Inc. since January 2013. Mr. Schneebaum served as Chief Executive Officer and Member of the Board of Predictive Biosciences, Inc., since 2011 until January 2013 and served as its President. He served as Chief Executive Officer, President and Director of Sensors for Medicine and Science Inc. (also known as Senseonics Holdings, Inc) from 1997 to 2010 and served as its Chief Operating Officer since May 1997. He spent the previous 13 years with Sensors for Medicine and Science, Inc. He served as a consultant in the healthcare industry. Mr. Schneebaum served as a Senior Vice President of Finance & Business Development and Chief Financial Officer of Genetic Therapy, Inc. (GTI)., since 1991 until 1997. At Genetic Therapy, he completed a successful IPO and three additional public stock offerings and raised over id=mce_marker00 Million prior to participating in the negotiation and implementation of its merger with Sandoz AG (now Novartis). He began his career in the accounting and auditing group at KPMG, advancing to Senior Manager in the management consulting group. Mr. Schneebaum served as Vice President of Alex Brown & Sons Incorporated From 1987 to 1991. He serves on the board of the March of Dimes of Maryland. He serves as Director of Stemina Biomarker Discovery, Inc. He served as an Independent Director of GenVec, Inc. since April 19, 2007 until June 16, 2017. He is a Certified Public Accountant. Mr. Schneebaum received his Degree in Business Administration from the University of Maryland.

I leader HR

Nome e Titolo
Bio
Katie OVary  HR Generalist
Katie OVary
HR Generalist
Katie OVary serves as the HR Generalist of Madrigal Pharmaceuticals. Katie currently resides in the Reading, Pennsylvania Area.

Let Madrigal Pharmaceuticals sa che si desidera lavorare lì

Dici Madrigal Pharmaceuticals sei interessato a lavorare presso la società, pur mantenendo la vostra identità personale anonimo. Comparabilmente darà Madrigal Pharmaceuticals la possibilità di noleggiare you.When c'è un lavoro di apertura che è una misura faremo la partita accadere.

Leadership Score

trending upQuesto punteggio categoria è stata trend up % dal mese scorso
70
su 100
Valutazione Dirigente?
100
su 100
Valutazione CEO?
90
su 100
Valutazione Manager?

Compensazione Score

trending upQuesto punteggio categoria è stata trend up % dal mese scorso
AnswerPercent
100%
No0%
Pagato abbastanza?
AnswerPercent
100%
No0%
Soddisfatto con i benefici?

squadra Score

trending upQuesto punteggio categoria è stata trend up % dal mese scorso
AnswerPercent
100%
No0%
AnswerPercent
100%
No0%
interazione Colleghi?
100
su 100
Qualità di collaboratori?

Ambiente Score

trending upQuesto punteggio categoria è stata trend up % dal mese scorso
AnswerPercent
7 o meno100%
80%
100%
120%
Più di 120%
Ore lavorative al giorni?
AnswerPercent
estremamente veloce0%
comodamente veloce100%
Moderare0%
Un po 'lento0%
Burocratico0%
Pace sul posto di lavoro?
AnswerPercent
Positivo100%
Negativo0%
ambiente di lavoro positivo?

Outlook Score

trending upQuesto punteggio categoria è stata trend up % dal mese scorso
100
su 100
Prospettive future?
AnswerPercent
Fantastico100%
Buono0%
Neutro0%
Male0%
Terribile0%
percezione del cliente?
AnswerPercent
0%
No100%
Contento di andare a lavoro?

genere Score Come positivamente il giudizio delle donne la loro esperienza presso Madrigal Pharmaceuticals

N/A

diversità Score Come positivamente minoranze valutano la loro esperienza presso Madrigal Pharmaceuticals

N/A

eNPS

Net Promoter Score tracce punteggio complessivo dei dipendenti a questa domanda: "Su una scala 1-10, quante probabilità ci sono di raccomandare lavora presso la vostra azienda ad un amico?"
100
ENPS Score
100%Promoters
0%Passives
0%Detractors

Madrigal Pharmaceuticals Concorrenti

  1. 1st
    Biogen
    75 / 100
  2. 2nd
    Madrigal Pharmaceuticals
    0 / 100
  3. 3rd
    MyoKardia
    0 / 100
  4. 4th
    Reata Pharmaceuticals
    0 / 100

Conosci qualcuno che lavora a Madrigal Pharmaceuticals?

Inviare loro un invito a valutare la cultura aziendale.

Anonimo Invia invito

×
Rate your company